Middle-East and Africa Bio Pharmaceuticals market anticipated to touch USD 22.52 billion by 2021
Middle-East and Africa Bio Pharmaceuticals market by Product Type, by Therapeutic Type, and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (20162021)
(EMAILWIRE.COM, December 09, 2017 ) According to the report Middle-East and Africa Bio Pharmaceuticals market published by Market Data Forecast, the Middle-East and Africa market is projected to reach USD 22.52 billion by 2021, at a CAGR of 9.16% from 2016 to 2021.
Biopharmaceuticals are among the most sophisticated and elegant achievements of modern science. The huge, complex structures of these drugs dont just look extraordinary in the 3-D modeling systems used to design them; they also perform their jobs remarkably well, offering high efficacy and few side effects. And there is much more to come: existing treatment archetypes are evolving and becoming more sophisticated all the time, and continuing research is yielding entirely new types of products. Radically new concepts are making it to the market, such as the cell therapy
Development of biopharmaceutical product is being undertaken by increasing number of competitors in the pharmaceutical industry. Market players are more focusing on expanding the biologics pipeline, relying on the fact that commercialization of biopharmaceuticals will reduce the usage of traditional small molecular drugs. Pharmaceutical industries mainly rely on biopharmaceuticals for profits and innovation.
Get a comprehensive overview of the Middle-East and Africa Bio Pharmaceuticals market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-bio-pharmaceuticals-market-638/
Middle-East and Africa Bio Pharmaceuticals market: Drivers & Restraints
Biopharmaceuticals are in huge demand due to the growing incidence of chronic diseases, which is one of the key drivers, increasing the growth of the global biopharmaceuticals market. Chronic diseases are growing due to unhealthy lifestyle, poor diet, excess alcohol consumption, and lack of physical activity. The restraints related with the global biopharmaceuticals market include high cost of biopharmaceuticals and side effects, such as breathing problems, sore throat, allergic reactions, itching, and rashes due to the consumption of biopharmaceuticals.
Get accurate market forecast and analysis on the Middle-East and Africa Bio Pharmaceuticals market. Request a sample to stay up-to-date on the main trends affecting this market http://www.marketdataforecast.com/market-reports/middle-east-and-africa-bio-pharmaceuticals-market-638/request-sample
Middle-East and Africa Bio Pharmaceuticals market: Segmentation
By Product Type
Monoclonal Antibodies (mAb)
Erythropoietin
Biotech Vaccines
Recombinant Human (RH) Insulin
Granulocyte colony-stimulating factor (G-CSF)
Interferon
Human growth hormones (HGH)
By Therapeutic Type
Neurology
Infectious diseases
Diabetes
Oncology
Cardiovascular
Other Therapeutic Areas
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/middle-east-and-africa-bio-pharmaceuticals-market-638/customize-report
Middle-East and Africa Bio Pharmaceuticals market: Overview
Monoclonal antibodies segment holds the highest number of shares in the product sector. This is due to technological advancements in the region. In terms of types, monoclonal antibodies are the fastest growing segment. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market. Biopharmaceuticals have wide applications in the pharmaceutical industry.
The biopharmaceutical market witnessed 1517% revenue growth in 2004, which is more than double the growth rate of the global pharmaceutical market. With revenues of $45 billion in 2004, the global biopharmaceutical sector accounted for approximately 8.1% of the total global pharmaceutical market. Revenues are anticipated to reach $92 billion in 2011, at an average annual growth rate (AAGR) of 10.3% for the period 20042011. Projects in the pipeline and continued research advances are likely to foster the growth of this segment further. Biopharmaceuticals account for about 2530% of the total product pipeline
Middle-East and Africa Bio Pharmaceuticals market: Region-wise Outlook
Based on geography the market is analysed under various regions namely, Middle-East and Africa. Africa market is estimated to grow at highest rate in the region. Some of the major countries that hold significant place in this market include UAE, Saudi Arabia, South Africa and Qatar.
Key Questions Answered
What are the major players in this industry and the key strategies adopted by them to sustain and grow in the studied Middle-East and Africa market ?
What is the current and future Bio Pharmaceuticals Market outlook in Middle-East and Africa? What trends are affecting the Middle-East and Africa market?
What is the competitive landscape and market share of major players in the Bio Pharmaceuticals space in Middle-East and Africa?
What are the key, high growth markets that Bio Pharmaceuticals manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Bio Pharmaceuticals currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Bio Pharmaceuticals?
What are the challenges and barriers that have hindered widespread adoption of Bio Pharmaceuticals?
Middle-East and Africa Bio Pharmaceuticals market: Key Players
Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc., and Novartis AG are some of the leading players in the market for biopharmaceuticals.
Reasons to buy Middle-East and Africa Bio Pharmaceuticals market Report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Middle East & Africa Antiviral Drugs Market: http://www.marketdataforecast.com/market-reports/Middle-East-and-Africa-antiviral-drugs-market-1592/
Middle East and Africa Antivenom Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-antivenom-market-1585/
Middle-East & Africa Anticoccidial Drugs Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-anticoccidial-drugs-market-27/
Middle-East and Africa Cancer Monoclonal Antibodies Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-cancer-monoclonal-antibodies-market-190/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com.
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Biopharmaceuticals are among the most sophisticated and elegant achievements of modern science. The huge, complex structures of these drugs dont just look extraordinary in the 3-D modeling systems used to design them; they also perform their jobs remarkably well, offering high efficacy and few side effects. And there is much more to come: existing treatment archetypes are evolving and becoming more sophisticated all the time, and continuing research is yielding entirely new types of products. Radically new concepts are making it to the market, such as the cell therapy
Development of biopharmaceutical product is being undertaken by increasing number of competitors in the pharmaceutical industry. Market players are more focusing on expanding the biologics pipeline, relying on the fact that commercialization of biopharmaceuticals will reduce the usage of traditional small molecular drugs. Pharmaceutical industries mainly rely on biopharmaceuticals for profits and innovation.
Get a comprehensive overview of the Middle-East and Africa Bio Pharmaceuticals market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-bio-pharmaceuticals-market-638/
Middle-East and Africa Bio Pharmaceuticals market: Drivers & Restraints
Biopharmaceuticals are in huge demand due to the growing incidence of chronic diseases, which is one of the key drivers, increasing the growth of the global biopharmaceuticals market. Chronic diseases are growing due to unhealthy lifestyle, poor diet, excess alcohol consumption, and lack of physical activity. The restraints related with the global biopharmaceuticals market include high cost of biopharmaceuticals and side effects, such as breathing problems, sore throat, allergic reactions, itching, and rashes due to the consumption of biopharmaceuticals.
Get accurate market forecast and analysis on the Middle-East and Africa Bio Pharmaceuticals market. Request a sample to stay up-to-date on the main trends affecting this market http://www.marketdataforecast.com/market-reports/middle-east-and-africa-bio-pharmaceuticals-market-638/request-sample
Middle-East and Africa Bio Pharmaceuticals market: Segmentation
By Product Type
Monoclonal Antibodies (mAb)
Erythropoietin
Biotech Vaccines
Recombinant Human (RH) Insulin
Granulocyte colony-stimulating factor (G-CSF)
Interferon
Human growth hormones (HGH)
By Therapeutic Type
Neurology
Infectious diseases
Diabetes
Oncology
Cardiovascular
Other Therapeutic Areas
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/middle-east-and-africa-bio-pharmaceuticals-market-638/customize-report
Middle-East and Africa Bio Pharmaceuticals market: Overview
Monoclonal antibodies segment holds the highest number of shares in the product sector. This is due to technological advancements in the region. In terms of types, monoclonal antibodies are the fastest growing segment. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market. Biopharmaceuticals have wide applications in the pharmaceutical industry.
The biopharmaceutical market witnessed 1517% revenue growth in 2004, which is more than double the growth rate of the global pharmaceutical market. With revenues of $45 billion in 2004, the global biopharmaceutical sector accounted for approximately 8.1% of the total global pharmaceutical market. Revenues are anticipated to reach $92 billion in 2011, at an average annual growth rate (AAGR) of 10.3% for the period 20042011. Projects in the pipeline and continued research advances are likely to foster the growth of this segment further. Biopharmaceuticals account for about 2530% of the total product pipeline
Middle-East and Africa Bio Pharmaceuticals market: Region-wise Outlook
Based on geography the market is analysed under various regions namely, Middle-East and Africa. Africa market is estimated to grow at highest rate in the region. Some of the major countries that hold significant place in this market include UAE, Saudi Arabia, South Africa and Qatar.
Key Questions Answered
What are the major players in this industry and the key strategies adopted by them to sustain and grow in the studied Middle-East and Africa market ?
What is the current and future Bio Pharmaceuticals Market outlook in Middle-East and Africa? What trends are affecting the Middle-East and Africa market?
What is the competitive landscape and market share of major players in the Bio Pharmaceuticals space in Middle-East and Africa?
What are the key, high growth markets that Bio Pharmaceuticals manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Bio Pharmaceuticals currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Bio Pharmaceuticals?
What are the challenges and barriers that have hindered widespread adoption of Bio Pharmaceuticals?
Middle-East and Africa Bio Pharmaceuticals market: Key Players
Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc., and Novartis AG are some of the leading players in the market for biopharmaceuticals.
Reasons to buy Middle-East and Africa Bio Pharmaceuticals market Report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Middle East & Africa Antiviral Drugs Market: http://www.marketdataforecast.com/market-reports/Middle-East-and-Africa-antiviral-drugs-market-1592/
Middle East and Africa Antivenom Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-antivenom-market-1585/
Middle-East & Africa Anticoccidial Drugs Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-anticoccidial-drugs-market-27/
Middle-East and Africa Cancer Monoclonal Antibodies Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-cancer-monoclonal-antibodies-market-190/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com.
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results